A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2009
12/08/2009	CA2359242C Growth differentiation factor inhibitors and uses therefor
12/08/2009	CA2358289C Amide derivatives for antiangiogenic and/or antitumorigenic use
12/08/2009	CA2355075C Heteroaryl-cyclic acetals
12/08/2009	CA2347424C Use of dextran covalently bound to charged groups for selective targeting of tumor by local, intratumoral or intracavitary administration
12/08/2009	CA2322845C Emulsion preconcentrates containing cyclosporin or a macrolide
12/08/2009	CA2315113C Pyridones as src family sh2 domain inhibitors
12/08/2009	CA2292846C Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/08/2009	CA2292757C Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties
12/08/2009	CA2266584C Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
12/08/2009	CA2163012C Anti-egfr single-chain fvs and anti-egfr antibodies
12/03/2009	WO2009146406A1 Purine pi3k inhibitor compounds and methods of use
12/03/2009	WO2009146218A2 Compounds including an anti-inflammatory pharmacore and methods of use
12/03/2009	WO2009146216A2 Antioxidant inflammation modulators: novel derivatives of oleanolic acid
12/03/2009	WO2009146112A1 Compositions and methods for inhibiting sphingosine kinase
12/03/2009	WO2009146099A2 Contrast agents, methods for preparing contrast agents, and methods of imaging
12/03/2009	WO2009146034A2 Mapk/erk kinase inhibitors and methods of use thereof
12/03/2009	WO2009146013A1 Myosin light chain phosphatase inhibitors
12/03/2009	WO2009145899A1 5-substituted isoindoline compounds
12/03/2009	WO2009145856A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009	WO2009145852A1 Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof
12/03/2009	WO2009145841A1 Compositions and methods for immunotherapy
12/03/2009	WO2009145489A2 Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component
12/03/2009	WO2009145243A1 Lipid membrane applicable to photodynamic therapy and application thereof
12/03/2009	WO2009144775A1 Anti-tumor agent
12/03/2009	WO2009144738A1 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin
12/03/2009	WO2009144719A2 Methods of killing cells and use of same in prevention and treatment of cancer
12/03/2009	WO2009144699A1 Methods of treating cancer of the central nervous system
12/03/2009	WO2009144584A1 Anti-ligands molecules and biological applications
12/03/2009	WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009	WO2009144395A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009	WO2009144394A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2- α] pyridine derivatives, and preparation and therapeutic use thereof
12/03/2009	WO2009144392A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009	WO2009144391A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009	WO2009144220A1 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
12/03/2009	WO2009144009A1 Medical intervention in haematological cancers
12/03/2009	WO2009143945A1 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
12/03/2009	WO2009143715A1 Retinoid derivative and pharmaceutical composition and use thereof
12/03/2009	WO2009143714A1 2,4-dihydroxyl chalcone derivative, process for preparing them and use thereof
12/03/2009	WO2009143611A1 Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
12/03/2009	WO2009143610A1 Modulating interstitial pressure and oncolytic viral delivery and distribution
12/03/2009	WO2009143578A1 Cancer drug target and methods of diagnosis and therapy
12/03/2009	WO2009122288A3 Liquid and freeze dried formulations
12/03/2009	WO2009122034A3 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/03/2009	WO2009118296A3 Novel substituted imidazoquinolines
12/03/2009	WO2009115572A3 Novel heterocyclic compounds and uses therof
12/03/2009	WO2009114623A3 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same
12/03/2009	WO2009109862A3 S100a6 and/or s100a4 inhibitors for treating cancer
12/03/2009	WO2009108633A3 Sphingosine 1-phosphate antagonism
12/03/2009	WO2009108388A3 Enzymatic production or chemical synthesis and uses for 5,7-dienes and uvb conversion products thereof
12/03/2009	WO2009107983A3 Stabilized single-liquid pharmaceutical composition containing docetaxel
12/03/2009	WO2009103476A8 Antitumoral agents with a benzophenanthridine structure and formulations containing them
12/03/2009	WO2009095872A3 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
12/03/2009	WO2009089260A3 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
12/03/2009	WO2009089147A3 Methods and compositions for the treatment of cancers and pathogenic infections
12/03/2009	WO2009088831A3 Method of inhibiting abcg2 and other treatment methods
12/03/2009	WO2009077741A3 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents
12/03/2009	WO2009053854A3 Polymorphs of dasatinib and process for preparation thereof
12/03/2009	WO2009043479A3 Use of eaa-mart1 (26-35) for the treatment of human cytomegalovirus infections
12/03/2009	WO2009043478A3 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections
12/03/2009	WO2008026219A3 Novel polymorphs of rimonabant
12/03/2009	WO2007138334A3 Methods for identifying an agent that modulates type i or type ii pip kinase activity or expression
12/03/2009	US20090299127 Magnet-Field Controlled Active Substance Transfer for Aerosol Therapy
12/03/2009	US20090299039 Anti-a33 antibody
12/03/2009	US20090298939 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals
12/03/2009	US20090298925 Substituted benzopyrans as selective estrogen receptor-beta agonists
12/03/2009	US20090298917 Non-Viral Vector System For The Delivery Of Nucleic Acid Into The Lung
12/03/2009	US20090298906 Proteasome inhibitors
12/03/2009	US20090298886 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
12/03/2009	US20090298883 N-piperidinyl acetamide derivatives as calcium channel blockers
12/03/2009	US20090298882 Thioxoisoindoline compounds and compositions comprising and methods of using the same
12/03/2009	US20090298876 Modulators of atp-binding cassette transporters
12/03/2009	US20090298855 Protein Tyrosine Kinase Inhibitors
12/03/2009	US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells
12/03/2009	US20090298846 such as 6-[2-(4-Hydroxyphenyl)ethylamino]-11H-indolo[3,2-c]quinoline, used to inhibit both growth of cancer cells and activity of telomerase
12/03/2009	US20090298845 Piperazinyl derivatives as modulators of chemokine receptor activity
12/03/2009	US20090298837 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis
12/03/2009	US20090298836 Thiadiazole modulators of PKB
12/03/2009	US20090298833 Piperidinyl derivatives as modulators of chemokine receptor activity
12/03/2009	US20090298821 Hydroxy and alkoxy substituted ih-imidazonaphthyridines and methods
12/03/2009	US20090298820 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/03/2009	US20090298815 Benzene Sulfonamide Thiazole and Oxazole Compounds
12/03/2009	US20090298800 1,25-dihydroxy, 20-cyclopropyl,26-27-deuteroalkyl vitamin d3 compounds and methods of use thereof
12/03/2009	US20090298791 Combinations comprising epothilones and antimetabolites
12/03/2009	US20090298785 Method for Treating Ocular Cancer
12/03/2009	US20090298784 Isolation and structure of turbostatins 1-4
12/03/2009	US20090298765 Metastin derivatives and use thereof
12/03/2009	US20090298754 Hai-1 and hai-2 in cancer therapy
12/03/2009	US20090298752 Aplidine treatment of cancers
12/03/2009	US20090298177 Dat1
12/03/2009	US20090298156 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
12/03/2009	US20090297622 Separation and formulation of bioactive fraction and subfraction from camel urine work as anticancer agent
12/03/2009	US20090297612 Homogeneous, intrinsic radiopaque embolic particles
12/03/2009	US20090297536 Compositions, kits, and methods for identification, assessment, prevention and therapy of cancer
12/03/2009	US20090297535 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
12/03/2009	US20090297532 Antibody Neutralizers of Human Granulocyte Macrophage Colony Stimulating Factor
12/03/2009	US20090297525 Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
12/03/2009	US20090297521 Cd33-specific single-chain immunotoxin and methods of use
12/03/2009	US20090297519 ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272
12/03/2009	US20090297518 Immunopotentiative composition
12/03/2009	US20090297512 Compositions and methods for modulating vascular development

1 ... 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 ... 2211